Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia

Area of Science:

• Hematology
• Pediatric Oncology
• Stem Cell Transplantation

Background:

• Severe aplastic anemia (SAA) affects over 400 children annually in the US.
• A growing number of children with SAA have had stem cells collected via cord blood banking.
• Autologous cord blood transplantation is an emerging therapeutic option for pediatric hematologic disorders.

Observation:

• A nine-year-old male diagnosed with SAA was treated with a novel approach.
• The patient received immunoablative chemotherapy followed by an autologous cord blood transplant.
• This treatment strategy was chosen due to the availability of cryopreserved autologous cord blood.

Findings:

• The autologous cord blood transplant was successful in treating the pediatric patient with SAA.
• The patient experienced a positive outcome with no major complications reported during the follow-up period.
• This case demonstrates the feasibility and efficacy of using autologous cord blood for SAA treatment.

Implications:

• Autologous cord blood transplantation may be considered as an initial therapeutic option for pediatric SAA.
• Further research is warranted to establish standardized protocols for preparative regimens and manage potential complications.
• This approach could offer a valuable alternative for patients with SAA, especially those with cryopreserved cord blood.